Skip to main content
. 2015 Feb 2;6:45–53. doi: 10.2147/JBM.S75784

Figure 1.

Figure 1

Survival outcomes based on A-LMR. (A) Overall survival, (B) progression-free survival, (C) lymphoma-specific survival, and (D) time to progression. Validation set. (E) Overall survival, (F) progression-free survival, (G) lymphoma-specific survival, and (H) time to progression.

Abbreviation: A-LMR, autograft lymphocyte/monocyte ratio.